ERK-Mediated Regulation of ncRNAs: In hepatocellular carcinoma (HCC), hyperactivation of the BRAF/MEK/ERK pathway drives tumor proliferation and drug resistance by modulating lncRNAs. This evidence concerns the gene MAPK1 and neoplasm.